Fundz

Helocyte, Inc. reported raising $1 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEJul 15, 2016$1M of $5M raised

Amount Raised

$1 Million

$1 Million sold, per SEC Form D (first sale Jul 15, 2016)

Round Type

Seed

New YorkBiotechnology

Quick answer

Helocyte, Inc. raised $1 Million in a Seed round, dated July 15, 2016. Helocyte, Inc. is based in New York, New York, United States.

How much did Helocyte, Inc. raise?
Helocyte, Inc. raised $1 Million in a Seed round on July 15, 2016.
What does Helocyte, Inc. do?
Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.
Where is Helocyte, Inc. based and how big is it?
Helocyte, Inc. is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Helocyte, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Metabolon raised $15M on August 25, 2016.
  • Boston Therapeutics, Inc. raised $1.3M (Seed) on August 25, 2016.
  • ProMIS Neurosciences raised $158K on August 24, 2016.
  • mBio Diagnostics, Inc. raised $563K (Seed) on August 24, 2016.
  • BT Manufacturing raised $250K on August 24, 2016.
  • AcuFocus, Inc. raised $2M (Seed) on August 24, 2016.

Who to call at Helocyte, Inc., and when

A new round usually means Helocyte, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Helocyte, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Helocyte, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Helocyte, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Helocyte, Inc.

Location

2 GANSEVOORT STREET

New York, New York, United States

About

Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Helocyte, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Helocyte, Inc.'s next move

See what Strategic adds

Helocyte, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.